Kidney transplantation from a hepatitis C virus (HCV)-positive donor to an HCV-negative recipient till recently has been a contraindication. In view of the excellent sustained virological response (SVR) rates with directly acting antiviral agents, HCV-positive donors are being considered for the HCV-negative recipients in a few centers. We report the successful transplantation of an HCV-negative recipient transplanted with an HCV-positive donor kidney. Donor was treated with sofosbuvir and ribavirin for 12 weeks. At 10 and 16 weeks of starting treatment, her HCV-RNA PCR was negative. Three weeks later, transplantation was performed with basiliximab induction and triple immunosuppression with tacrolimus, mycophenolate, and prednisolone. The recipient was administered sofosbuvir and ribavirin for 12 weeks. He attained good graft function with a stable creatinine. His serial alanine transaminases were normal on 3, 6, and 12 months, respectively. Six months posttransplant his anti-HCV antibody, and HCV-RNA PCR were negative.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309394PMC
http://dx.doi.org/10.4103/ijn.IJN_267_17DOI Listing

Publication Analysis

Top Keywords

kidney transplantation
8
transplantation hepatitis
8
hcv-positive donor
8
hcv-negative recipient
8
sofosbuvir ribavirin
8
ribavirin weeks
8
hcv-rna pcr
8
pcr negative
8
hepatitis virus-positive
4
donor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!